Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research

Baixin Ye1, Qingping Gao1, Zhi Zeng2

  • 1Department of Hematology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.

Insights

Single-cell sequencing (SCS) offers a powerful method to analyze cancer

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Cancer cellular heterogeneity poses challenges for targeted therapy development.
  • Understanding cellular diversity is crucial for advancing cancer treatment strategies.

Purpose of the Study:

  • To provide an overview of single-cell sequencing (SCS) technology.
  • To review the current applications of SCS in clinical oncology and research.

Main Methods:

  • Single-cell sequencing (SCS) involves isolating individual cells.
  • Genetic material is then isolated and amplified for analysis.
  • Genomic, transcriptomic, and epigenomic data are described.

Main Results:

  • SCS enables genome-wide analysis of genetic polymorphisms in single cells.
  • The technology can be applied to tumor biopsies and circulating tumor cells.
  • SCS aids in understanding tumor progression and metastasis.

Conclusions:

  • Single-cell sequencing is a critical tool for characterizing oncologic cellular heterogeneity.
  • SCS applications hold significant potential for improving cancer therapies and research.
  • Further development and application of SCS are essential for personalized oncology.